Abstract:Nutrition exerts considerable effects on health, and dietary interventions are commonly used to treat diseases of metabolic aetiology. Although cancer has a substantial metabolic component1, the principles that define whether nutrition may be used to influence outcomes of cancer are unclear2. Nevertheless, it is established that targeting metabolic pathways with pharmacological agents or radiation can sometimes lead to controlled therapeutic outcomes. By contrast, whether specific dietary interventions can influence the metabolic pathways that are targeted in standard cancer therapies is not known. Here we show that dietary restriction of the essential amino acid methionine-the reduction of which has anti-ageing and anti-obesogenic properties-influences cancer outcome, through controlled and reproducible changes to one-carbon metabolism. This pathway metabolizes methionine and is the target of a variety of cancer interventions that involve chemotherapy and radiation. Methionine restriction produced therapeutic responses in two patient-derived xenograft models of chemotherapy-resistant RAS-driven colorectal cancer, and in a mouse model of autochthonous soft-tissue sarcoma driven by a G12D mutation in KRAS and knockout of p53 (KrasG12D/+;Trp53-/-) that is resistant to radiation. Metabolomics revealed that the therapeutic mechanisms operate via tumour-cell-autonomous effects on flux through one-carbon metabolism that affects redox and nucleotide metabolism-and thus interact with the antimetabolite or radiation intervention. In a controlled and tolerated feeding study in humans, methionine restriction resulted in effects on systemic metabolism that were similar to those obtained in mice. These findings provide evidence that a targeted dietary manipulation can specifically affect tumour-cell metabolism to mediate broad aspects of cancer outcome.

Influence of Methionine/valine-Depleted Enteral Nutrition on Nucleic Acid and Protein Metabolism in Tumor-Bearing Rats.

Effect of Complex Amino Acid Imbalance on Growth of Tumor in Tumor-Bearing Rats

Experimental And Clinical Studies On The Antitumor Effect Of L-Methionine-Deprived Total Parenteral Nutrition

Influence of Imbalanced branched-chain Amino Acids on host nutritional and survival condition of tumor-bearing rats during chemotherapy

Parenteral Vs Enteral Nutrition in Tumor-Bearing Rats.

Influence of Imbalance Amino Acids on Tumor Growth,Host Nutritional Condition and Survival Time in Tumor-bearing Rats

Influence of imbalance amino acid solutions on tumor growth in tumor-bearing rats

Research progress of methionine dependence inhibition of tumor growth

Applying Proteomic Methodologies to Analyze the Effect of Methionine Restriction on Proliferation of Human Gastric Cancer SGC7901 Cells.

Influence of arginine on protein metabolism of tumor and host in cancer-bearing status

Effect of Enteral Immunonutrition on Host Nutritional Status and Immune in Cancer Cachexia Mice

Methionine Sulfoximine Intensifies Cancer Anorexia

A Study of Preoperative Methionine-Depleting Parenteral Nutrition Plus Chemotherapy in Gastric Cancer Patients

Effect of dietary fatty acids on tumorigenesis of colon cancer induced by methyl nitrosourea in rats

Regulation of Nucleotide Metabolism with Nutrient‐Sensing Nanodrugs for Cancer Therapy

Tumor Necrosis Factor-Α Alters Protein Metabolism and Cell-Cycle Kinetics in Malignant Tumor

Dietary Methionine Influences Therapy in Mouse Cancer Models and Alters Human Metabolism

STUDY ON THE EFFECT OF DIFFERENT DIETARY FATTY ACID COMPOSITIONS ON MNU-INDUCED BREAST TUMORS IN RATS

Inhibition of the Growth of Cultured NIH 3T3 Cell and Human Hepatoma Bel7402 Cell by Methionine Enkephalin

Assessment of the Effect of Betaine on P16 and C-Myc DNA Methylation and Mrna Expression in a Chemical Induced Rat Liver Cancer Model

Effects of Methionine Deficiency on Nutrient Composition, No, Nos Activity and Mrna Expression in Nf-κb Signal Pathway of the Liver and Kidney in Broiler